Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | PPARG | P37231 | 4/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2901186 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2258630 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL5164976 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2228492 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL4444012 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2258628 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL1129947 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL4746641 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2901187 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH | |
| SCHEMBL2900343 | 1.00 | FFAR1 (0.59) | FFAR1FFAR4PTPN1GPR84FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117642376-A | Polyfatty acid salt compounds for treating substrates based on fibrous amino acids, in particular hair | 迈图高新材料有限责任公司 | 2024-03-01 | — | — | CN | claimed |
| EP-0408693-B1 | MIXTURES OF STABILIZERS FOR PLASTICS | BASF AG (DE) | 1993-11-10 | — | — | EP | claimed |
| JP-5320617-A | — | — | None | — | — | JP | disclosed |
| CN-108158836-B | Method for lightening skin | 联合利华知识产权控股有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118251464-A | Polymer composition and method for preparing same | 赢创运营有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-117986927-A | Ink compositions and films with narrow band emissive phosphor materials | 通用电气公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117642376-A | Polyfatty acid salt compounds for treating substrates based on fibrous amino acids, in particular hair | 迈图高新材料有限责任公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-113881718-B | Method for preparing grease composition rich in free fatty acid by using two-step enzyme catalysis method and application | 江南大学 | 2023-10-13 | — | — | CN | disclosed |
| EP-3877469-A1 | ALKYD RESIN-BASED ANTI-CORROSION COMPOSITION | Sika Technology AG (CH) | 2021-09-15 | — | — | EP | disclosed |
| US-10583119-B2 | Compounds, compositions and methods for making the same | SIGNUM BIOSCIENCES, INC. (US) | 2020-03-10 | — | — | US | disclosed |
| EP-2282735-B1 | PP2A MODULATORS FOR TREATING ALZHEIMER, PARKINSON, DIABETES | SIGNUM BIOSCIENCES INC (US) | 2019-01-16 | — | — | EP | disclosed |
| EP-0296506-B1 | FERMENTATIVE PRODUCTION OF DICARBOXYLIC ACIDS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1993-04-21 | — | — | EP | disclosed |
| US-5130440-A | PROCESS FOR THE PRODUCTION OF 2-ALKYL- OR ALKENYL-2-OXAZOLINES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1992-07-14 | — | — | US | disclosed |
| EP-0229252-B1 | PROCESS FOR THE PRODUCTION OF DICARBOXYLIC ACIDS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1992-07-01 | — | — | EP | disclosed |
| EP-0408693-A1 | MIXTURES OF STABILIZERS FOR PLASTICS. | BASF AG (DE) | 1991-01-23 | — | — | EP | disclosed |
| WO-1990007547-A1 | MIXTURES OF STABILIZERS FOR PLASTICS | BASF AKTIENGESELLSCHAFT (DE) | 1990-07-12 | — | — | WO | disclosed |
| EP-0296506-A2 | Fermentative production of dicarboxylic acids | Henkel Kommanditgesellschaft auf Aktien (DE) | 1988-12-28 | — | — | EP | disclosed |
| EP-0230043-A2 | Process for hydration of unsaturated carboxylic acids | FORSCHUNGSZENTRUM JÜLICH GMBH (DE) | 1987-07-29 | — | — | EP | disclosed |
| EP-0229252-A2 | Process for the production of dicarboxylic acids | Henkel Kommanditgesellschaft auf Aktien (DE) | 1987-07-22 | — | — | EP | disclosed |
| US-4562007-A | ESTERIFICATION USING FATTY ACID IN PRESENCE OF BASIC CATALYST | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10583119-B2 | Compounds, compositions and methods for making the same | PPP2CA, PPP4C, PPP6C | FFAR1 4605/4885FFAR4 4663/4885PTPN1 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.